Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regul

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

Neuronetics NASDAQ: STIM reported second-quarter 2026 revenue growth, a sharply narrower net loss an

Neuronetics (STIM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Esti

Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's

MALVERN, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics” or t

MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interv

New location expands access to advanced mental health treatments while serving as Greenbrook's flags

MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interv

Neuronetics, Inc. (NASDAQ:STIM), a leader in interventional mental health that combines its NeuroSta

MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interv

BTIG initiated coverage of Neuronetics Inc. (NASDAQ:STIM) on Monday, noting that the company is ente

BTIG initiates coverage on Neuronetics (STIM) with a Buy rating and $5 target as shares surge 28%. R

Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's

BTIG analyst Sam Eiber initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and anno

Neuronetics is revisited following prior coverage in March 2026. The article focuses on STIM's recen

MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interv

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technolo

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technolo

MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technolog

Neuronetics, Inc. (STIM) Q1 2026 Earnings Call Transcript

Neuronetics (STIM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Esti

MALVERN, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “N

MALVERN, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stag

MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a

Policy Update Broadens Access to Innovative, Non-Drug Depression Treatment Across 26 States and Wash

MALVERN, Pa. , April 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company"),

Delivers Letter to STIM Board Outlining Potential 5-7x Upside for Shareholders Inherent in Sale of T

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acqu

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

  On Wednesday, 311 stocks hit new 52-week lows.

  On Tuesday, 647 companies set new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

  On Thursday, 283 companies set new 52-week lows.